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↑ What is "already known" in this topic: {#box1}
========================================

Epidermolysis bullosa simplex (EBS) is one of the most common genetic bullous skin diseases characterized by the separation of the skin at the basal keratinocytes region after trauma and blister formation. The most important and most commonly occurring molecular defects in these patients are the defects of keratins 5 and14 (*KRT5* and *KRT14*).

→ What this article adds: {#box2}
=========================

Exons 1 and 6-7 of *KRT5* and exons 1 and 4-7 of *KRT14* mutation detection were performed in this study. The results of molecular analyzing showed that the most severe phenotypes were associated with mutations in highly conserved regions. In some cases, different inheritance modes were observed. These mutations showed regional variations useful in genetic counseling and prenatal testing in different ethnic groups. Our data demonstrated the heterogenic status of *KRT5* and *KRT14* genes mutations.

Introduction {#s1}
============

Epidermolysis bullosa simplex (EBS) is a group of genodermatoses characterized by fragility of the skin and separation of tissue through basal keratinocytes that resulted in intraepidermal blistering upon mild mechanical trauma ([@R1]). Among all EB cases, the most common subtype is EBS, with an approximate prevalence of 1 in 25 000--50 000 ([@R2], [@R3]). However, the prevalence of EBS in Iran remains unknown. Localized EBS (the mildest form), generalized intermediate EBS, EBS-with mottled pigmentation and generalized severe EBS (Dowling-Meara type) are the most common subtypes of EBS ([@R4], [@R5]).

The underlying mutations in EBS are mostly affected by *KRT5* and *KRT14*. These genes encode keratin 5 (K5) and 14 (K14) that typically expressed in the epidermal basal layer ([@R6], [@R7]). Keratin filaments are part of cytoskeletal intermediate filament proteins. Interactions between keratin 5 and 14 filaments using their α-helical rod domains to bundle formation have essential roles for strength and flexibility to basal keratinocytes and maintenance of epidermis integrity and resilience against physical traumas ([@R7]-[@R10]). Recessive mutations are usually reported in *KRT14* gene, while dominant mutations (especially missense mutations) have been seen in both genes ([@R11]-[@R13]). In the Western world (with a low prevalence of consanguineous marriage) remarkable proportion of EBS cases have autosomal dominant inheritance pattern, whereas in regions or countries with a high prevalence of inbreeding, autosomal recessive inheritance is more prevalent ([@R11], [@R14]). Through analysis of phenotype-genotype correlation has been revealed that mutation in highly conserved regions in keratin molecule (two terminals of the central rod section) is usually related to a severe phenotype (generalized severe EBS). Mutations in less conserved areas are related to milder phenotypes (e.g., Localized EBS) ([@R15]-[@R17]). Moreover, the nature of the amino acid alteration affects the severity of the disease ([@R18], [@R19]).

In this study, we carried out the analysis of molecular genetics of keratin mutations in 12 families of Iranian patients suspected to Epidermolysis bullosa simplex to investigate the mode of inheritance and correlation between genotype-phenotype. At the end of this study, we debate how these molecular alterations create different phenotypic manifestations.

Methods {#s2}
=======

*Patient selection:* According to precise clinical examinations, family history and pattern of inheritance, 15 patients in 12 families diagnosed with EBS. Criteria of diagnosis for patient selection and their classification were based on the report of the Third international consensus meeting on diagnosis and classification of Epidermolysis bullosa ([@R20]). After approval by the Medical Ethics Committee of Iran University of Medical Sciences, all patients and their families contributed to this study with fully informed consent for sample collection and sequencing of DNA. Then 5 ml of blood was collected into Ethylenediaminetetraacetic acid tubes from patients and their relatives.

*PCR and Mutation detection:* Genomic DNA was isolated from peripheral blood leukocytes using the salting-out method ([@R21]). Polymerase chain reaction (PCR) amplification of *KRT5* exons 1, 6-7, *KRT14* exons 1, 4-7 and their flanking intronic sequences performed. The sequence of primers used for PCR amplification of the specific amplicons was described previously ([Table 1](#T1){ref-type="table"}) ([@R22]). Each PCR reaction was contained 12.5 µl of PCR master mix, 2.5 µl of genomic DNA (Approximately 100-150 ng of DNA), 0.4µl of forward primer (with a concentration of 10 pmol/ul), 0.4µl of reverse primer (with a concentration of 10 pmol/ul) and 9.2µl of double-distilled water. Initial denaturation at 94 ^0^C for 5 min and then 30 amplification cycles were performed with a program contained 1 min at 94 ^0^C, 1 min at 60 ^0^C and 1 min at 72 ^0^C with a final incubation of 5 min at 72 ^0^C for all of the exons were the same except primers of *KRT14* exon 4-7 that their annealing temperature was 63 ^0^C (to avoid amplification of the *KRT14* pseudogene). PCR Products purified and sequenced (using ABI 3730XL DNA Sequencer by Macrogen Company). For the detection of mutations, PCR product sequences were compared with sequences obtained from GenBank accession number NM_000424.3 as a reference sequence for *KRT5* and GenBank accession number NM_000526.3 as a reference sequence for *KRT14* (<http://www.ncbi.nlm.nih.gov/>).

###### Primers and their sequences

  ------------- ------------------------------ ------------------------
  Gene / exon   Primer ( Sequence 5' to 3' )   
  Forward       Reverse                        
  KRT5/e1       AGCTCTGTTCTCTCCAGCAC           CAGTCTAATTCAGAACGTGTCC
  KRT5/e6-7     TCACTGCCTGTGAACTTTGG           GGCCATGAGTCAGACTGAAA
  KRT14/e1      TTACCCGAGCACCTTCTCTTC          TGCTGGAGAACAAGTAGCTGC
  KRT14/e4-7    GGCCTAAGGAACACCAATCC           CACTAGAGCTCAGCCCCTCA
  ------------- ------------------------------ ------------------------

Results {#s3}
=======

*Phenotypic observations:* From the 12 families, 15 affected individuals were clinically evaluated ([Table 2](#T2){ref-type="table"}). An explicit EBS-DM (Dowling--Meara) phenotype in four probands from 4 unrelated families and an ambiguous phenotype in an intermediate mode between Dowling--Meara and Koebner type in one patient (patient 5) were observed. Three patients from 2 unrelated families showed EBS with mottled pigmentation phenotype. Five patients from 3 different families had a Koebner type of EBS. Also, 2 patients in 2 separate families showed a Weber‐Cockayne phenotype. The eldest and youngest patients were 48 and 4 years old, respectively. The prevalence of consanguineous marriages among the selected families was 58.3% and families were from several different Iranian ethnic groups. Clinical features of patients have been shown in [Figure 1](#F1){ref-type="fig"}.

###### Families, patients and their features

  -------- --------- -------- ----- ---------------------- ------------------------------------------------------------------------------------------------------
  Family   Patient   Sex      Age   Phenotype              Clinical features

  1        1         Female   52    mottled pigmentation   Spontaneous blistering after a minor trauma\
                                                           Nail dystrophy ([Fig. 2a](#F2){ref-type="fig"})\
                                                           Reticulate skin pigmentation\
                                                           Keratoderma

           2         Male     27                           

  2        3         Male     7     Dowling--Meara         Onset age: at birth\
                                                           Blisters in herpetiform clusters on the trunk and proximal extremities\
                                                           Nail dystrophy and then nail losing\
                                                           Mucosal involvement: esophagus\
                                                           Teeth involvement

  3        4         Male     10    Koebner type           Onset age: early infancy\
                                                           Blistering after minor trauma ([Fig. 2c](#F2){ref-type="fig"})\
                                                           Mucosal involvement\
                                                           Teeth involvement\
                                                           Nail losing\
                                                           Hyperkeratosis of the palms and soles

  4        5         Male     48    Dowling--Meara         Onset age: at birth\
                                                           Nail dystrophy ([Fig. 2b](#F2){ref-type="fig"}) and then nail losing\
                                                           Mucosal involvement: esophagus\
                                                           Teeth involvement\
                                                           Hypopigmentation and hyperpigmentation ([Fig. 2b](#F2){ref-type="fig"})

  5        6         Male     36    Weber‐Cockayne         Onset age: adolescence\
                                                           Blistering: typically restricted to hands and feet\
                                                           Healing of blisters with minor scarring

  6        7         Male     6     Weber‐Cockayne\        Onset age: early infancy\
                                    And\                   Blistering in whole body surface that typically restricted to hands and feet (after a minor trauma)\
                                    Koebner type           Mucosal involvement\
                                                           Nail losing (2 fingers)

  7        8         Female   8     Dowling--Meara         Onset age: at birth\
                                                           Blisters in herpetiform clusters on the trunk and proximal extremities\
                                                           Nail dystrophy and then nail losing\
                                                           Mucosal involvement: esophagus\
                                                           Progressive hyperkeratosis of the palms

  8        9         Female   8     Dowling--Meara         Onset age: at birth\
                                                           Blisters in herpetiform clusters on the trunk and proximal extremities\
                                                           Nail losing\
                                                           Mucosal involvement: esophagus\
                                                           Milia

  9        10        Female   12    Dowling--Meara         Onset age: at birth\
                                                           Generalized blistering\
                                                           Mucosal involvement: esophagus\
                                                           Progressive hyperkeratosis of the palms\
                                                           Nail losing\
                                                           Milia\
                                                           Progressive hyperkeratosis of the soles

  10       11        Male     24    Koebner type           Onset age: early infancy\
                                                           Nail dystrophy and then nail losing\
                                                           Mucosal involvement: esophagus\
                                                           Hypopigmentation and hyperpigmentation\
                                                           Hyperkeratosis of the palms and soles

           12        Male     31                           

           13        Male     22                           

  11       14        Female   41    Koebner type           Onset age: early infancy\
                                                           Generalized blistering after a minor trauma\
                                                           Nail losing\
                                                           Teeth involvement\
                                                           Mucosal involvement\
                                                           Hypopigmentation and hyperpigmentation

  12       15        Female   38    mottled pigmentation   Onset age: at birth\
                                                           Occasionally Skin blistering: restricted to hands and feet\
                                                           Reticulate skin pigmentation
  -------- --------- -------- ----- ---------------------- ------------------------------------------------------------------------------------------------------
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*Keratin mutation identification:* Sequence analysis of the *KRT5* and *KRT14* genes revealed 9 variants that are listed in [Table 3](#T3){ref-type="table"} and [Figure 2](#F2){ref-type="fig"}. Four variants have not been reported previously and five are known. 8 of 9 variants were missense and one was nonsense. Four novel variants with probable pathologic importance in *KRT5* were c.289T\>A in exon 1(patients 1, 2 and 15), c.1190G\>T in exon 6 and c.1330C\>T in exon 7(patient 14), c.1249G\>C in exon 7(patient 5). Despite the previous report from two variants \[c.287G\>A and c.275G\>A in exon 1 of *KRT5*\], no association has been reported between EBS and these variants so far. Three formerly reported mutations, also detected (two in exon 6 of *KRT14*: c.1130T\>C (patient 7), c.1237G\>A (patient 4) and c.1431G\>C in exon 7 of *KRT5* (patient 5)).
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###### All variants found in the *KRT5* and KRT14 genes in this study

  ------------ --------------------------- ---------------- --------------------
  Patient      Effect on coding sequence   HGVS coding      HGVS Protein level
  KRT5                                                      
  1 and 2      Missense                    c.287G\>A        G96D
  1,2 and 15   Missense                    c.289T\>A (N)    F97I
  4            Missense                    c.275G\>A        G92E
  14           Missense                    c.1190G\>T (N)   R397I
  14           Nonsense                    c.1330C\>T (N)   Q444\*
  5            Missense                    c.1249G\>C (N)   A417P
  5            Missense                    c.1431G\>C       E477D
  KRT14                                                     
  7            Missense                    c.1130T\>C       I377T
  4            Missense                    c.1237G\>A       A413T
  ------------ --------------------------- ---------------- --------------------

Discussion {#s4}
==========

In this study, we identified 9 important variants. Among the identified variants, four of them were not reported previously ([Table 3](#T3){ref-type="table"}).

In family 1 (patients 1 and 2), a mother and her son affected by EBS showed mottled pigmentation phenotype with an autosomal dominant inheritance. Interestingly, their clinical features ([Table 2](#T2){ref-type="table"}) were modified and reduced symptom severity over time. Two heterozygous variants identified in *KRT5* gene were located within the head domain of keratin 5 protein ([Fig. 2a](#F2){ref-type="fig"}). Since the mutations in this region appeared to be consistent with mottled pigmentation phenotype, therefore a genotype-phenotype correlation was observed ([@R23]). The first variant, which is considered as a disease-causing variant, is c.287G\>A with G96D (p.Gly96Asp) effect. According to the ACMG guideline, this variant is considered as an Uncertain Significance by getting scores PP3, PP4 (due to patient's phenotype highly specific for the gene) and PM2 (because of this variant absent in South Asian population). The other variant (c.289T\>A with F97I (p.Phe97Ile) effect) was a novel genetic variant. According to the ACMG guidelines by getting score PM2, this variant is considered as Uncertain Significance. Patient 15 (in family 12) had very milder symptoms than family 1 and unexpectedly carried de novo c.289T\>A variant. This suggests that this variant has a possible synergic genetic effect with c.287G\>A variant.

Patient 4 (in family 3) was one of the interesting cases in this study because of having a double heterozygous state for *KRT5* and *KRT14* genes. His clinical features were concordant with EBS, Koebner type. An important identified variant was c.1237G\>A in *KRT14* gene. First report of this variant was in a Taiwanese patient with EBS, Koebner type ([@R24]). However, in the study conducted by Ken Natsuga et al. ([@R25]), in a Japanese family, three normal Japanese had c.1237G\>A transition (p.Ala413Thr) within *KRT14* and they did not have any history of skin fragility or nail dystrophy. But what is more challenging, is a case report of EBS, Koebner type (generalized intermediate) by Wakiguchi et al. ([@R26]), which is a double heterozygote patient; it is described that one of the causative mutations was c.1237G\>A (p.Ala413Thr) in *KRT14* and another mutation in *KRT5*. In the mentioned study, mother and sister of the patient were asymptomatic and carried c.1237G\>A in the *KRT14* gene, but no mutation in *KRT5* gene. Another important variant found in patient 4, was c.275G\>A in *KRT5* gene with G92E (p.Gly92Glu) effect. This variant is located in the head domain of keratin 5 protein ([Fig. 2a](#F2){ref-type="fig"}) and according to the ACMG guideline, considered as Uncertain Significance (because of two scores: PP3 and PM2). However, it is important to note that c.1237G\>A in *KRT14* is located in the terminal site of the helix2B motif (IF rod) ([Fig. 2b](#F2){ref-type="fig"}) and is concordant with the phenotype of the patient. Therefore the presence of these two variants maybe suggested a digenic pattern of inheritance.

An unequivocal Koebner type phenotype was observed in patient 14(in family 11). Mutation analysis revealed two novel variants in *KRT5* gene in a compound heterozygous state and an autosomal recessive inheritance in this patient. Both of these variants are located in the helix 2B motif (IF rod domain) of keratin5 protein ([Fig. 2a](#F2){ref-type="fig"}) that is concordant with the patient\'s phenotype (genotype-phenotype correlation). The first variant is a nonsense variant (c.1330C\>T) in exon 7 of *KRT5* with Q444\* (p.Gln444Ter) effect. c.1330C\>T in *KRT5* by getting PM1, PM2, PP3 and PVS1 ACMG scores classified as a Pathogenic variant. Another novel variant is c.1190G\>T (p.Arg397Ile) in exon 6 of *KRT5*. ACMG scores for this variant are PM1, PM2, and PP3 that fall into the Uncertain Significance category.

An unclear intermediate phenotype between Dowling--Meara and Koebner type was characterized by a probable autosomal recessive inheritance that was observed in patient 5. This patient was compound heterozygous for both variants c.1249G\>C and c.1431G\>C in *KRT5* gene. Both were located at the helix 2B motif (IF rod domain) of keratin 5 protein ([Fig. 2a](#F2){ref-type="fig"}) and they were correlated with Dowling--Meara patient\'s phenotype. c.1249G\>C was a novel variant (being PM1, PM2 and PP3) and considered as an Uncertain Significance. c.1431G\>C transition in *KRT5* (E477D (p.Glu477Asp)) in a heterozygous state was previously reported in a patient with EB simplex Dowling--Meara accompanied by verrucous carcinoma ([@R27]). However, a study by Homberg M et al. ([@R28]), suggested that E477D in Keratin 5 for causing severe generalized EBS requires genetic modifiers. The probable genetic modifier for this phenotype in patient 5 can be 1249G\>C variant.

The c.1130T\>C transition in exon 6 of *KRT14* gene (I377T (p.Ile377Thr)) was found in a homozygous state in patient 7(in family 6). This mutation was first previously reported by Rugg EL et al. ([@R29]) in a patient with localized EBS (Weber‐Cockayne) and subsequently, in 2016, it was described by Vahidnezhad H et al. ([@R30]) in a large Iranian family with a high degree of consanguineous marriage. According to their observations, semi-dominant inheritance was suggested for this genetic alteration and its impacts ([@R30]). However, in this study, the patient\'s clinical features ([Table 2](#T2){ref-type="table"}) were severe while his mother and father were asymptomatic (only have minor blisters in the sole of the foot after a long walking). Therefore, it was difficult to determine the inheritance pattern. However, it appears that the homozygous state caused Koebner type; and the heterozygous state developed Weber‐Cockayne.

In this study, 15 EBS patients were screened for sequence variation in exons 1, 6-7 of *KRT5* and exons 1, 4-7 of *KRT14*. Seven of them were described at the molecular level. Patients with no variation in mentioned exons might have mutations in other exons of *KRT5* and *KRT14* or other genes with overlapping phenotypes such as PLEC,COL17A1 and ITGB4 ([@R23], [@R31]). Moreover, para mutations as epigenetic phenomena may also be involved in the pathogenesis of EBS ([@R32]).

Conclusion {#s5}
==========

We found 9 important variants in *KRT5* and *KRT14* genes. According to Our data, for rapid mutation screening of EBS, we recommend mutation analysis of the hotspots of these genes. Genotype-phenotype correlation can be useful for the interpretation of molecular variants. Finally, next generation sequencing can be an alternative method for mutation detection and copy number variation analysis in patients with EBS.
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